Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Dizziness; Low blood pressure; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of dizziness in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included IBANDRONATE SODIUM (BONIVA) for prophylaxis. In OCT-2019, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, the patient received BONIVA. On an unknown date, an unknown time after receiving Shingrix and BONIVA, the patient experienced dizziness (Verbatim: Dizziness) and low blood pressure (Verbatim: Low blood pressure). The outcome of the dizziness and low blood pressure were resolved. The reporter considered the dizziness and low blood pressure to be related to Shingrix. It was unknown if the reporter considered the dizziness and low blood pressure to be related to BONIVA. The company considered the dizziness and low blood pressure to be related to Shingrix. It was unknown if the company considered the dizziness and low blood pressure to be related to BONIVA. Linked case(s) involving the same patient: US2025AMR120590 Additional Information: GSK Receipt Date: 17-SEP-2025 Patient had a similar reaction to a Boniva shot as well. Had the same reaction to both doses of Shingrix. This was 1 of the 2 linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2025AMR120590:Same patient/different dose
BONIVA